Takeda Pharmaceutical's expenditure on R&D FY 2011-2018

In fiscal year 2018, the Japanese pharmaceutical company Takeda Pharmaceutical Co., Ltd recorded R&D expenses amounting to approximately 368 billion Japanese yen, up from around 325 billion yen in the previous year. The company focuses mainly on the therapeutic areas oncology, gastroenterology and neuroscience.

Research and development expenses of Takeda Pharmaceutical Co., Ltd. from fiscal year 2011 to 2018

Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

May 2019

Region

Japan

Survey time period

fiscal years 2011 to 2018; the company’s fiscal year starts on April 1 of the stated year and ends on March 31 of the following year

Special properties

consolidated data of Takeda Pharmaceutical Co., Ltd. and its subsidiaries

Supplementary notes

Takeda has adopted International Financial Reporting Standards (IFRS) from fiscal 2013 ended March 31, 2014 and the disclosure information in this material is based on IFRS. According to this adoption, the previous year's information is also based on IFRS.

Figures prior to fiscal year fiscal year 2017 come from previous reporting.
Figures have been rounded.

1 Japanese yen equals 0.00943 U.S. dollars or 0.00862 euros as of September 2019.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.